Table 2.
Synthesis of the results of the biomarkers of the male patient who died after being affected by COVID-19.
| Blood biomarkers | |||||||
|---|---|---|---|---|---|---|---|
| RBC | Hb | Hct | MCV | ||||
| Reference value | Result | Reference value | Result | Reference value | Result | Reference value | Result |
| 4.4–6.6 million/μL | 4.42 | 13–18 | 13.8 | 39–54% | 42.3% | 76–96 | 95.7 |
| MCH | MCHC | Total leukocytes | RDW | ||||
| Reference value | Result | Reference value | Result | Reference value | Result | Reference value | Result |
| 27 - 33 | 31.2 | 32–36 | 32.6 | 4.000–10.000/μL | 5.430 | 11–15 | 13.6 |
| Serum ferritin | Transferrin saturation | B12 vitamin | Homocysteine | ||||
| Reference value | Result | Reference value | Result | Reference value | Result | Reference value | Result |
| 23.90 and 336.20 ng/mL | 161.2 | 20–50% | 20.8 | 210.0–980.0 pg/mL | 153 | 5–15 μmol/L | 16.5 |
| C-reactive protein | Fibrinogen | 25-Hydroxy-vitamin D3 | Apolipoprotein A-1 | ||||
| Reference value | Result | Reference value | Result | Reference value | Result | Reference value | Result |
| <0.3 mg/dL | 1.74 | 200–400 mg/dL | 395 | >30 | 21.6 | 104–202 mg/100 mL | 142 |
| Apolipoprotein B | Glutamic oxalacetic transaminase | Glutamic-pyruvic transaminase | Gamma GT | ||||
| Reference value | Result | Reference value | Result | Reference value | Result | Reference value | Result |
| 66–133 mg/100 mL | 113 | <34 U/L | 17 | 10–49 U/L | 11 | 7–45 U/L | 67 |
| Total cholesterol | Triglycerides | HDL | LDL | ||||
| Reference value | Result | Reference value | Result | Reference value | Result | Reference value | Result |
| <190 mg/dL | 200 | <150 mg/dL | 611 | >40 mg/dL | 42 | <130 – Low Risk | 36 |
| CT/HDL ratio | TG/HDL ratio | LDL/HDL ratio | APO B/APO A1 ratio | ||||
| Reference value | Result | Reference value | Result | Reference value | Result | Reference value | Result |
| ≤3.3 | 4.76 | ≤2.5 | 14.4 | ≤2.3 | 0.85 | ≤0.5 | 0.7957 |